Dashboard
1
High Management Efficiency with a high ROE of 11.53%
2
Company has very low debt and has enough cash to service the debt requirements
3
Poor long term growth as Operating profit has grown by an annual rate 3.98% of over the last 5 years
4
The company has declared Negative results for the last 5 consecutive quarters
5
With ROE of 11.48%, it has a very attractive valuation with a 1.97 Price to Book Value
6
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.6%
0%
-6.6%
6 Months
-1.62%
0%
-1.62%
1 Year
9.43%
0%
9.43%
2 Years
-4.55%
0%
-4.55%
3 Years
14.23%
0%
14.23%
4 Years
38.84%
0%
38.84%
5 Years
-2.09%
0%
-2.09%
Sundrug Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.35%
EBIT Growth (5y)
3.98%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
2.76
Tax Ratio
29.42%
Dividend Payout Ratio
49.45%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
23.70%
ROE (avg)
11.53%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
1.97
EV to EBIT
11.33
EV to EBITDA
8.17
EV to Capital Employed
2.07
EV to Sales
0.63
PEG Ratio
3.17
Dividend Yield
NA
ROCE (Latest)
18.28%
ROE (Latest)
11.48%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Jun 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
207,698.00
194,565.00
6.75%
Operating Profit (PBDIT) excl Other Income
16,640.00
14,894.00
11.72%
Interest
80.00
20.00
300.00%
Exceptional Items
-3.00
2.00
-250.00%
Consolidate Net Profit
7,944.00
7,290.00
8.97%
Operating Profit Margin (Excl OI)
59.10%
56.10%
0.30%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 6.75% vs 6.82% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 8.97% vs 5.65% in Jun 2024
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
801,811.00
751,777.00
6.66%
Operating Profit (PBDIT) excl Other Income
61,894.00
56,239.00
10.06%
Interest
164.00
32.00
412.50%
Exceptional Items
-292.00
-356.00
17.98%
Consolidate Net Profit
30,750.00
29,126.00
5.58%
Operating Profit Margin (Excl OI)
55.50%
54.50%
0.10%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 6.66% vs 8.88% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 5.58% vs 13.32% in Mar 2024
About Sundrug Co., Ltd. 
Sundrug Co., Ltd.
Retailing
No Details Available.
Company Coordinates 
No Company Details Available






